Department of Chemistry, Scripps Research, La Jolla, California 92037, United States.
Vividion Therapeutics, San Diego, California 92121, United States.
J Am Chem Soc. 2024 Apr 17;146(15):10393-10406. doi: 10.1021/jacs.3c13448. Epub 2024 Apr 3.
Covalent chemistry coupled with activity-based protein profiling (ABPP) offers a versatile way to discover ligands for proteins in native biological systems. Here, we describe a set of stereo- and regiochemically defined spirocycle acrylamides and the analysis of these electrophilic "stereoprobes" in human cancer cells by cysteine-directed ABPP. Despite showing attenuated reactivity compared to structurally related azetidine acrylamide stereoprobes, the spirocycle acrylamides preferentially liganded specific cysteines on diverse protein classes. One compound termed ZL-12A promoted the degradation of the TFIIH helicase ERCC3. Interestingly, ZL-12A reacts with the same cysteine (C342) in ERCC3 as the natural product triptolide, which did not lead to ERCC3 degradation but instead causes collateral loss of RNA polymerases. ZL-12A and triptolide cross-antagonized one another's protein degradation profiles. Finally, we provide evidence that the antihypertension drug spironolactone─previously found to promote ERCC3 degradation through an enigmatic mechanism─also reacts with ERCC3_C342. Our findings thus describe monofunctional degraders of ERCC3 and highlight how covalent ligands targeting the same cysteine can produce strikingly different functional outcomes.
共价化学结合基于活性的蛋白质谱分析(ABPP)为在天然生物系统中发现蛋白质配体提供了一种通用的方法。在这里,我们描述了一组立体和区域化学定义的螺环丙烯酰胺,并通过半胱氨酸定向 ABPP 分析了这些亲电“立体探针”在人类癌细胞中的作用。尽管与结构相关的氮杂环丁烷丙烯酰胺立体探针相比,反应性减弱,但螺环丙烯酰胺优先与不同蛋白质类别的特定半胱氨酸结合。一种称为 ZL-12A 的化合物促进了 TFIIH 解旋酶 ERCC3 的降解。有趣的是,ZL-12A 与 ERCC3 中的天然产物雷公藤内酯反应的半胱氨酸(C342)相同,雷公藤内酯不会导致 ERCC3 降解,而是导致 RNA 聚合酶的附带损失。ZL-12A 和雷公藤内酯相互拮抗彼此的蛋白质降解谱。最后,我们提供的证据表明,降压药螺内酯——以前通过一种神秘的机制被发现促进 ERCC3 降解——也与 ERCC3_C342 反应。我们的发现因此描述了 ERCC3 的单功能降解剂,并强调了靶向相同半胱氨酸的共价配体如何产生截然不同的功能结果。